UPDATED Apr 28, 2024
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AMRX | US$5.94 | 10.6% | 219.4% | US$1.8b | US$7.31 | PB92.7x | E104.9% | 0% | ||
INVA | US$15.54 | 4.1% | 32.9% | US$964.8m | US$15.00 | PE5.5x | S5.5% | 0% | ||
PRPH | US$4.61 | -5.9% | -40.6% | US$85.0m | US$21.00 | PS1.9x | E87.4% | 0% | ||
AZTA | US$53.21 | 4.5% | 22.0% | US$2.9b | US$66.80 | PS4.6x | E54.2% | 0% | ||
ABCM | US$23.99 | 0.08% | 54.7% | US$5.5b | US$23.66 | PE1758.5x | E39.3% | 0% | ||
TEVA | US$14.10 | 9.5% | 59.5% | US$15.6b | US$15.74 | PS1x | E32.1% | 0% | ||
IQV | US$235.48 | 1.8% | 23.9% | US$42.8b | US$275.38 | PE31.6x | E12.9% | 0% |